Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
2(15%)
Results Posted
43%(3 trials)
Terminated
2(15%)

Phase Distribution

Ph phase_3
2
15%
Ph phase_1
2
15%
Ph early_phase_1
1
8%
Ph phase_2
3
23%
Ph not_applicable
2
15%
Ph phase_4
2
15%

Phase Distribution

3

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
3(25.0%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
2(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(7)
Terminated(2)
Other(2)

Detailed Status

Completed7
Terminated2
unknown2
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (8.3%)
Phase 12 (16.7%)
Phase 23 (25.0%)
Phase 32 (16.7%)
Phase 42 (16.7%)
N/A2 (16.7%)

Trials by Status

active_not_recruiting18%
recruiting18%
terminated215%
unknown215%
completed754%

Recent Activity

2 active trials
Showing 5 of 13
terminatedphase_2

ACTH in Progressive Forms of MS

NCT01950234
active_not_recruitingphase_2

Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome

NCT05279118
recruitingearly_phase_1

Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

NCT03905603
unknownnot_applicable

ACTH vs Betamethasone in Hospitalized Patients With Acute Gout

NCT04306653
completedphase_3

ACTH for Fatigue in Multiple Sclerosis Patients

NCT02315872
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT01950234Phase 2

ACTH in Progressive Forms of MS

Terminated
NCT05279118Phase 2

Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome

Active Not Recruiting
NCT03905603Early Phase 1

Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Recruiting
NCT04306653Not Applicable

ACTH vs Betamethasone in Hospitalized Patients With Acute Gout

Unknown
NCT02315872Phase 3

ACTH for Fatigue in Multiple Sclerosis Patients

Completed
NCT00950781

Cortisol Levels on Menopausal Symptoms - Ancillary (Addendum) Study to Protocol 16997

Completed
NCT02132195Phase 3

Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome

Completed
NCT02092883Phase 4

Evaluation of Neuroinflammation in Children With Infantile Spasms

Completed
NCT01049451Phase 1

Pulse ACTH vs. MP for MS

Completed
NCT02972346Not Applicable

Availability Study of ACTH to Treat Children SRNS/SDNS

Unknown
NCT00947895Phase 2

Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone

Terminated
NCT00805753Phase 1

Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy

Completed
NCT01028287Phase 4

Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13